CAS: 124401-38-3; 4-Methyl-3-Oxo-N-Phenylpentanamide

该化合物是一个有机化合物,其特点是其氨化功能组,其特性来自一个含碳酸酸的矿山的反应.该化合物的特性是苯基组,该组有其芳香特性,以及异丁烯酸,表明存在一个分支乙酰基化合物组.该结构表明,由于该组不同功能组的独特组合,可能会在制药或农用化学品中应用可能带来特定的生物活动.一般而言,这种性质的化合物在标准条件下表现出中度至高度稳定性,但其再活性可能因存在分组和整体分子结构而不同.溶性特性也各不相同,在有机溶剂中往往具有溶解性,同时在水中表现出有限的溶解性.与许多有机化合物一样,应当参考安全数据,以了解与处理和使用有关的任何潜在危害.

结构式图片

相似化合物

25233-46-9 124401-38-3 4433-78-7

上下游产品

N-乙酰乙酰苯胺 N-Phenylacetoacetamide 102-01-2

合成工艺路线路线简述

    Tert-Butyl (2-((5-Methyl-4-Oxo-3-(Phenylcarbamoyl)Hex-2-En-2-yl)Amino)Ethyl)Carbamate置于三氟乙酸体系中,用 二氯甲烷 用作溶剂,化学反应 0.67H,以88%的收率获得4-甲基-3-酮基-N-苯基戊酰胺
    参考文献:基于烯胺的多米诺策略用于乙酰乙酰胺的 C-酰化/脱乙酰:β-酮酰胺的实际合成
    标题:基于烯胺的多米诺策略用于乙酰乙酰胺的 C-酰化/脱乙酰:β-酮酰胺的实际合成
    摘要:描述了乙酰乙酰胺的 C-酰化/脱乙酰化的实用三步路线.乙酰乙酰胺与 Boc 单保护乙二胺的初始烯化提供 β-烯氨基酰胺,其在 α-碳上以优异的选择性酰化.C-酰化衍生物在酸性介质中发生多米诺断裂,得到相应的α-酮酰胺,并伴随有 2-甲基-4,5-二氢-1H-咪唑.
    Doi:10.1055/s-0029-1219836

    海关参考信息

    专利信息


    专利号:US-8124790-B2
    优先权日:2008-01-02
    标题:Preparation process useful in synthesis of atorvastatin
    发明人:CHO DONG-OCK; KWON YOUNJA; CHA KYEONG-HOI; KIM YEONGSOOK; TAE HYUN-SEOP
    权利人:CHO DONG-OCK; KWON YOUNJA; CHA KYEONG-HOI; KIM YEONGSOOK; TAE HYUN-SEOP; MEDICHEM KOREA CO LTD
    摘要:The present invention relates to a preparation process useful in synthesis of atorvastatin, more particularly a process for preparing atorvastatin is effective in treating hyperlipemia, comprising protecting the dihydroxy group at C3 and C5 positions of the starting material cis-t-butyl-6-substituted-3,5-dihydroxy-hexanoate with trialkyl orthoformate, reducing the terminal nitro or cyano group to amine group, performing JV-alkylation by sequentially reacting with ethyl 4-fluorobenzene-2-haloacetate and isobutyryl chloride, cyclizing with JV,3-diphenylpropynamide, and performing deprotection and hydrolysis.

    专利号:US-6867306-B2
    优先权日:2001-01-19
    标题:Process for the synthesis of atorvastatin form v and phenylboronates as intermediate compounds
    发明人:SRINATH SUMITRA; MATHEW JOY; UJIRE SANDHYA; SRIDHARAN MADHAVAN; SAMBASIVAM GANESH
    权利人:BIOCON LTD
    摘要:The present invention discusses a novel process for the synthesis of [R-(R*,R*)]-2-(4-fluorophenyl)-B,D-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium, atorvastatin. The compound so prepared is useful as inhibitor of the HMG-CoA reductase and may thus be used as hypolipidemic and hypocholesterolemic agent.

    专利号:US-5998633-A
    优先权日:1996-07-29
    标 题:Process for the synthesis of protected esters of (S)-3,4-dihydroxybutyric acid
    发明人:JACKS THOMAS E; BUTLER DONALD E
    权利人:WARNER LAMBERT CO
    摘要:The invention is an improved process for the preparation of a compound of formula I wherein R and R 1 are each independently alkyl of from 1 to 3 carbon atoms; and R 2 is alkyl of from 1 to 8 carbon atoms. ##STR1##

    专利号:US-5155251-A
    优先权日:1991-10-11
    标题:Process for the synthesis of (5R)-1,1-dimethylethyl-6-cyano-5-hydroxy-3-oxo-hexanoate
    发明人:BUTLER DONALD E; LE TUNG V; MILLAR ALAN; NANNINGA THOMAS N
    权利人:WARNER LAMBERT CO
    摘要:An improved process for the preparation of (5R)-1,1-dimethylethyl-6-cyano-5-hydroxy-3-oxo-hexanoate is described where a halo hydroxyester or other activated dihydroxyester is converted in two steps to the desired product.

    专利号:US-5248793-A
    优先权日:1990-10-17
    标 题:Process for the synthesis of (4R-cis)-1,1-dimethylethyl 6-iodomethyl or 6-(phenyl-substituted)sulfonyloxymethyl-2,2-dimethyl-1,3-dioxane-4-acetate
    发明人:MILLAR ALAN; BUTLER DONALD E
    权利人:WARNER LAMBERT CO
    摘要:An improved process for the preparation of (4R-cis)-1,1-dimethylethyl 6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate is described where a hydroxy ester derivative is converted in two steps to the desired product, as well as valuable intermediates used in the process.

    专利号:US-5103024-A
    优先权日:1990-10-17
    标题:Process for the synthesis of (4r-cis)-1,1-dimethylethyl 6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate
    发明人:MILLAR ALLAN; BUTLER DONALD E
    权利人:WARNER LAMBERT CO
    摘要:An improved process for the preparation of (4R-cis)-1,1-dimethylethyl 6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate is described where a hydroxy ester derivative is converted in two steps to the desired product, as well as valuable intermediates used in the process.
    江西埃菲姆科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.afmpharm.com/
    电话: 793-33899567 13735087952👤
    📞江西埃菲姆科技有限公司 ⚠️参考联系方式

    销售电话:793-33899567 13735087952
    邮箱:sales@afmpharm.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Xu, L.; Wu, X.; Xiao, J., Science of Synthesis: Stereoselective Synthesis, (2011) 2, 291.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知